Corrigendum: Ginsenoside Re Attenuates High Glucose-Induced RF/6A Injury via Regulating PI3K/AKT Inhibited HIF-1a/VEGF Signaling Pathway

Saved in:
Bibliographic Details
Main Authors: Weijie Xie (Author), Ping Zhou (Author), Muwen Qu (Author), Ziru Dai (Author), Xuelian Zhang (Author), Chenyang Zhang (Author), Xi Dong (Author), Guibo Sun (Author), Xiaobo Sun (Author)
Format: Book
Published: Frontiers Media S.A., 2020-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_6fc9dbc8688e4a86bfd1edb80a45ab3c
042 |a dc 
100 1 0 |a Weijie Xie  |e author 
700 1 0 |a Ping Zhou  |e author 
700 1 0 |a Muwen Qu  |e author 
700 1 0 |a Ziru Dai  |e author 
700 1 0 |a Xuelian Zhang  |e author 
700 1 0 |a Chenyang Zhang  |e author 
700 1 0 |a Xi Dong  |e author 
700 1 0 |a Guibo Sun  |e author 
700 1 0 |a Xiaobo Sun  |e author 
245 0 0 |a Corrigendum: Ginsenoside Re Attenuates High Glucose-Induced RF/6A Injury via Regulating PI3K/AKT Inhibited HIF-1a/VEGF Signaling Pathway 
260 |b Frontiers Media S.A.,   |c 2020-10-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2020.01312 
546 |a EN 
690 |a ginsenoside Re 
690 |a diabetic retinopathy 
690 |a oxidative stress 
690 |a apoptosis 
690 |a phosphoinositide 3-kinase/AKTT 
690 |a hypoxia-inducible factor-1-alpha 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 11 (2020) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2020.01312/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/6fc9dbc8688e4a86bfd1edb80a45ab3c  |z Connect to this object online.